UK Markets open in 3 hrs 3 mins

SAP SE (SAPGF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
116.40-0.21 (-0.18%)
At close: 2:56PM EST
Full screen
Trade prices are not sourced from all markets
Previous close118.86
Open116.79
Bid0.00 x 0
Ask0.00 x 0
Day's range116.61 - 117.18
52-week range86.20 - 168.96
Volume209,498
Avg. volume26,210
Market cap139.689B
Beta (5Y monthly)0.97
PE ratio (TTM)28.12
EPS (TTM)4.14
Earnings dateN/A
Forward dividend & yield1.72 (1.48%)
Ex-dividend date21 May 2020
1y target estN/A
  • Business Wire

    The Peck Company Holdings to Participate at Benchmark Company’s 9th Annual Discovery 1x1 Investor Conference

    The Peck Company Holdings, Inc. (NASDAQ: PECK) (the "Company" or "Peck"), a leading commercial solar engineering, procurement and construction (EPC) company, today announced that Jeff Peck, Chief Executive Officer, John Sullivan, Chief Financial Officer, and Michael D’Amato, Chief Strategy Officer, will participate at Benchmark Company’s 9th Annual Discovery 1x1 Investor Conference. The virtual event will take place on Wednesday, November 1 8, 2020 with virtual 1x1 investor meetings throughout the day.

  • Business Wire

    Sunworks Terminates Merger Agreement with The Peck Company Holdings, Inc.

    The Peck Company Holdings, Inc. (NASDAQ: PECK) ("Peck"), a leading commercial solar engineering, procurement and construction (EPC) company was informed today by Sunworks, Inc. (NASDAQ: SUNW) ("Sunworks"), a provider of solar power solutions for agriculture, commercial and industrial ("ACI"), public works and residential markets, that the Merger Agreement previously announced on August 10, 2020 was terminated by Sunworks due to its inability to obtain stockholder approval.

  • CureVac CEO talks Tesla tie-up and Q3 2021 COVID-19 vaccine approval
    Yahoo Finance UK

    CureVac CEO talks Tesla tie-up and Q3 2021 COVID-19 vaccine approval

    The chief of Germany’s other leading vaccine developer, CureVac, says Tesla's RNA printers will allow for swift, localised vaccine production.